Osteolytic lesions in patients with relapse of diffuse large B-cell lymphoma treated with lenalidomide

Ann Hematol. 2014 Nov;93(11):1929-30. doi: 10.1007/s00277-014-2071-7. Epub 2014 Apr 8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Angiogenesis Inhibitors / adverse effects
  • Female
  • Humans
  • Lenalidomide
  • Lymphoma, Large B-Cell, Diffuse / diagnostic imaging*
  • Lymphoma, Large B-Cell, Diffuse / drug therapy
  • Middle Aged
  • Neoplasm Recurrence, Local / diagnostic imaging*
  • Neoplasm Recurrence, Local / drug therapy
  • Osteolysis / chemically induced*
  • Osteolysis / diagnostic imaging*
  • Radiography
  • Thalidomide / adverse effects
  • Thalidomide / analogs & derivatives*
  • Treatment Outcome

Substances

  • Angiogenesis Inhibitors
  • Thalidomide
  • Lenalidomide